Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
11.95
-0.47 (-3.78%)
At close: Aug 1, 2025, 4:00 PM
12.00
+0.05 (0.42%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Despegar.com Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Net Income
-71.47
Asset Writedown & Restructuring Costs
4
Stock-Based Compensation
4.54
Other Operating Activities
0.01
Change in Accounts Payable
29.31
Change in Other Net Operating Assets
8.54
Operating Cash Flow
-25.08
Total Debt Issued
149.92
Net Debt Issued (Repaid)
149.92
Issuance of Common Stock
1.26
Other Financing Activities
-3.04
Financing Cash Flow
164.14
Net Cash Flow
139.06
Updated Jun 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.